DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Agarwals Eye Hospital has allotted 1,32,827 equity shares at ₹5,270 per share (face value ₹10) to Dr. Agarwal's Health Care Limited (AHCL), a promoter group company, for a total consideration of approximately ₹70 crore (₹69,99,98,290). The allotment was approved by shareholders at the 31st AGM held on September 24, 2025, and received BSE in-principle approval on September 17, 2025. The newly issued shares will rank equally with existing equity shares. This is a preferential issue to the promoter group rather than to external investors.
This is a promoter-group capital infusion of around ₹70 crore, which strengthens the company's balance sheet without any dilution to public shareholders. The allotment price suggests a significant premium over face value, indicating strong valuation confidence from the promoter entity.